SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/12 – ‘XML’

On:  Friday, 3/15/13, at 4:50pm ET   ·   For:  12/31/12   ·   Accession #:  1193125-13-110112   ·   File #:  0-19627

Previous ‘10-K’:  ‘10-K/A’ on 7/6/12 for 12/31/11   ·   Next:  ‘10-K’ on 3/17/14 for 12/31/13   ·   Latest:  ‘10-K’ on 3/21/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/13  Biolase, Inc                      10-K       12/31/12   76:8.5M                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.11M 
 2: EX-21.1     Subsidiaries List                                   HTML     20K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
52: R1          Document and Entity Information                     HTML     53K 
41: R2          Consolidated Balance sheets                         HTML    144K 
50: R3          Consolidated Balance sheets (Parenthetical)         HTML     51K 
54: R4          Consolidated Statements of Operations and           HTML    121K 
                Comprehensive Loss                                               
70: R5          Consolidated Statements of Shareholders' Equity     HTML     97K 
                (Deficit)                                                        
43: R6          Consolidated Statements of Cash Flows               HTML    180K 
49: R7          Basis Of Presentation                               HTML     42K 
37: R8          Summary Of Significant Accounting Policies          HTML     97K 
28: R9          Supplementary Balance Sheet Information             HTML     67K 
71: R10         Intangible Assets And Goodwill                      HTML     52K 
56: R11         Lines Of Credit And Other Borrowings                HTML     36K 
55: R12         Income Taxes                                        HTML     87K 
61: R13         Commitments And Contingencies                       HTML     38K 
62: R14         Stockholders' Equity                                HTML    108K 
59: R15         Segment Information                                 HTML     37K 
63: R16         Concentrations                                      HTML     25K 
51: R17         Non-Recurring Event                                 HTML     25K 
53: R18         Subsequent Events                                   HTML     23K 
58: R19         Schedule II-Consolidated Valuation and Qualifying   HTML     41K 
                Accounts and Reserves                                            
76: R20         Basis Of Presentation (Policies)                    HTML    242K 
66: R21         Summary Of Significant Accounting Policies          HTML     59K 
                (Tables)                                                         
46: R22         Supplementary Balance Sheet Information (Tables)    HTML     72K 
57: R23         Intangible Assets And Goodwill (Tables)             HTML     43K 
48: R24         Income Taxes (Tables)                               HTML     84K 
22: R25         Commitments And Contingencies (Tables)              HTML     26K 
67: R26         Stockholders' Equity (Tables)                       HTML     83K 
73: R27         Segment Information (Tables)                        HTML     30K 
32: R28         Schedule II-Consolidated Valuation and Qualifying   HTML     39K 
                Accounts and Reserves (Tables)                                   
31: R29         Basis of Presentation - Additional Information      HTML     55K 
                (Detail)                                                         
35: R30         Estimated Useful Lives Of Property, Plant and       HTML     28K 
                Equipment (Detail)                                               
36: R31         Summary of Significant Accounting Policies -        HTML     98K 
                Additional Information (Detail)                                  
38: R32         Accrued Liabilities - Changes In Initial Product    HTML     41K 
                Warranty Accrual and Expenses Under Initial and                  
                Extended Warranties (Detail)                                     
20: R33         Classification Of Compensation Expense Associated   HTML     32K 
                With Share-Based Payments (Detail)                               
64: R34         Assumptions Used in Estimating Fair Value Of Stock  HTML     34K 
                Options Granted (Detail)                                         
45: R35         Components of Accounts Receivable, Net of           HTML     30K 
                Allowance (Detail)                                               
47: R36         Supplementary Balance Sheet Information -           HTML     52K 
                Additional Information (Detail)                                  
25: R37         Components of Inventory (Detail)                    HTML     34K 
75: R38         Summary of Property,Plant and Equipment (Detail)    HTML     39K 
14: R39         Components of Accrued Liabilities (Detail)          HTML     50K 
39: R40         Summary of Deferred Revenue (Detail)                HTML     40K 
69: R41         Intangible Assets And Goodwill - Additional         HTML     47K 
                Information (Detail)                                             
24: R42         Intangible Assets Related to Accumulated            HTML     54K 
                Amortization and Goodwill (Detail)                               
30: R43         Lines Of Credit And Other Borrowings - Additional   HTML    128K 
                Information (Detail)                                             
34: R44         Summary of Income Tax Current and Deferred          HTML     65K 
                Provision (Benefit) (Detail)                                     
42: R45         Federal Income Tax Provision Compared With          HTML     63K 
                Statutory Rates (Detail)                                         
19: R46         Summary of Net Deferred Tax Assets and Net          HTML     83K 
                Deferred Tax Liabilities (Detail)                                
27: R47         Income Taxes - Additional Information (Detail)      HTML     61K 
16: R48         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
68: R49         Commitments And Contingencies - Additional          HTML     38K 
                Information (Detail)                                             
23: R50         Future Minimum Rental Commitments Under Operating   HTML     45K 
                Lease Agreements (Detail)                                        
65: R51         Stockholders' Equity - Additional Information       HTML    163K 
                (Detail)                                                         
26: R52         Summary of Option Activity (Detail)                 HTML     83K 
40: R53         Options Outstanding and Exercisable (Detail)        HTML     70K 
15: R54         Cash Proceeds Along With Fair Value Disclosures     HTML     41K 
                Related to grants Exercises And Vesting Options                  
                (Detail)                                                         
17: R55         Segment Information - Additional Information        HTML     32K 
                (Detail)                                                         
33: R56         Summary of Net Revenue by Geographic Location       HTML     27K 
                (Detail)                                                         
21: R57         Concentrations - Additional Information (Detail)    HTML     36K 
72: R58         Non Recurring Event - Additional Information        HTML     36K 
                (Detail)                                                         
44: R59         Subsequent Events - Additional Information          HTML     30K 
                (Detail)                                                         
60: R60         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                Reserves (Detail)                                                
74: XML         IDEA XML File -- Filing Summary                      XML    115K 
29: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.02M 
 8: EX-101.INS  XBRL Instance -- biol-20121231                       XML   1.69M 
10: EX-101.CAL  XBRL Calculations -- biol-20121231_cal               XML    251K 
11: EX-101.DEF  XBRL Definitions -- biol-20121231_def                XML   1.09M 
12: EX-101.LAB  XBRL Labels -- biol-20121231_lab                     XML   1.77M 
13: EX-101.PRE  XBRL Presentations -- biol-20121231_pre              XML   1.22M 
 9: EX-101.SCH  XBRL Schema -- biol-20121231                         XSD    255K 
18: ZIP         XBRL Zipped Folder -- 0001193125-13-110112-xbrl      Zip    218K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<Version> 2.4.0.6 </Version>
<ProcessingTime/>
<ReportFormat> Html </ReportFormat>
<ContextCount> 226 </ContextCount>
<ElementCount> 446 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 72 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 11 </UnitCount>
<MyReports>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 101 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
</Report>
<Report>
<IsDefault> true </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 103 - Statement - Consolidated Balance sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified </Role>
<ShortName> Consolidated Balance sheets </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 104 - Statement - Consolidated Balance sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical </Role>
<ShortName> Consolidated Balance sheets (Parenthetical) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 105 - Statement - Consolidated Statements of Operations and Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/StatementOfIncome </Role>
<ShortName> Consolidated Statements of Operations and Comprehensive Loss </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 106 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome </Role>
<ShortName> Consolidated Statements of Shareholders' Equity (Deficit) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 107 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 108 - Disclosure - Basis Of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock </Role>
<ShortName> Basis Of Presentation </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 109 - Disclosure - Summary Of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock </Role>
<ShortName> Summary Of Significant Accounting Policies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 110 - Disclosure - Supplementary Balance Sheet Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlock </Role>
<ShortName> Supplementary Balance Sheet Information </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 111 - Disclosure - Intangible Assets And Goodwill </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock </Role>
<ShortName> Intangible Assets And Goodwill </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 112 - Disclosure - Lines Of Credit And Other Borrowings </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock </Role>
<ShortName> Lines Of Credit And Other Borrowings </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 113 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock </Role>
<ShortName> Income Taxes </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 114 - Disclosure - Commitments And Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock </Role>
<ShortName> Commitments And Contingencies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 115 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock </Role>
<ShortName> Stockholders' Equity </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 116 - Disclosure - Segment Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock </Role>
<ShortName> Segment Information </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 117 - Disclosure - Concentrations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock </Role>
<ShortName> Concentrations </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 118 - Disclosure - Non-Recurring Event </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsNonRecurringEvents </Role>
<ShortName> Non-Recurring Event </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 119 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock </Role>
<ShortName> Subsequent Events </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 120 - Disclosure - Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock </Role>
<ShortName> Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 121 - Disclosure - Basis Of Presentation (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies </Role>
<ShortName> Basis Of Presentation (Policies) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 122 - Disclosure - Summary Of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables </Role>
<ShortName> Summary Of Significant Accounting Policies (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 123 - Disclosure - Supplementary Balance Sheet Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlockTables </Role>
<ShortName> Supplementary Balance Sheet Information (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 124 - Disclosure - Intangible Assets And Goodwill (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables </Role>
<ShortName> Intangible Assets And Goodwill (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 125 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 126 - Disclosure - Commitments And Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables </Role>
<ShortName> Commitments And Contingencies (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 127 - Disclosure - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables </Role>
<ShortName> Stockholders' Equity (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 128 - Disclosure - Segment Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables </Role>
<ShortName> Segment Information (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 129 - Disclosure - Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockTables </Role>
<ShortName> Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 130 - Disclosure - Basis of Presentation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation </Role>
<ShortName> Basis of Presentation - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 131 - Disclosure - Estimated Useful Lives Of Property, Plant and Equipment (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureEstimatedUsefulLivesOfPropertyPlantAndEquipment </Role>
<ShortName> Estimated Useful Lives Of Property, Plant and Equipment (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 132 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation </Role>
<ShortName> Summary of Significant Accounting Policies - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 133 - Disclosure - Accrued Liabilities - Changes In Initial Product Warranty Accrual and Expenses Under Initial and Extended Warranties (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties </Role>
<ShortName> Accrued Liabilities - Changes In Initial Product Warranty Accrual and Expenses Under Initial and Extended Warranties (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 134 - Disclosure - Classification Of Compensation Expense Associated With Share-Based Payments (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments </Role>
<ShortName> Classification Of Compensation Expense Associated With Share-Based Payments (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 135 - Disclosure - Assumptions Used in Estimating Fair Value Of Stock Options Granted (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted </Role>
<ShortName> Assumptions Used in Estimating Fair Value Of Stock Options Granted (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 136 - Disclosure - Components of Accounts Receivable, Net of Allowance (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccountsReceivableNetOfAllowance </Role>
<ShortName> Components of Accounts Receivable, Net of Allowance (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 137 - Disclosure - Supplementary Balance Sheet Information - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSupplementaryBalanceSheetInformationAdditionalInformation </Role>
<ShortName> Supplementary Balance Sheet Information - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 138 - Disclosure - Components of Inventory (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureComponentsOfInventory </Role>
<ShortName> Components of Inventory (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 139 - Disclosure - Summary of Property,Plant and Equipment (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipment </Role>
<ShortName> Summary of Property,Plant and Equipment (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 140 - Disclosure - Components of Accrued Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccruedLiabilities </Role>
<ShortName> Components of Accrued Liabilities (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 141 - Disclosure - Summary of Deferred Revenue (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfDeferredRevenue </Role>
<ShortName> Summary of Deferred Revenue (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 142 - Disclosure - Intangible Assets And Goodwill - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation </Role>
<ShortName> Intangible Assets And Goodwill - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 143 - Disclosure - Intangible Assets Related to Accumulated Amortization and Goodwill (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill </Role>
<ShortName> Intangible Assets Related to Accumulated Amortization and Goodwill (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 144 - Disclosure - Lines Of Credit And Other Borrowings - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation </Role>
<ShortName> Lines Of Credit And Other Borrowings - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 145 - Disclosure - Summary of Income Tax Current and Deferred Provision (Benefit) (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfIncomeTaxCurrentAndDeferredProvisionBenefit </Role>
<ShortName> Summary of Income Tax Current and Deferred Provision (Benefit) (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 146 - Disclosure - Federal Income Tax Provision Compared With Statutory Rates (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureFederalIncomeTaxProvisionComparedWithStatutoryRates </Role>
<ShortName> Federal Income Tax Provision Compared With Statutory Rates (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 147 - Disclosure - Summary of Net Deferred Tax Assets and Net Deferred Tax Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetDeferredTaxAssetsAndNetDeferredTaxLiabilities </Role>
<ShortName> Summary of Net Deferred Tax Assets and Net Deferred Tax Liabilities (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 148 - Disclosure - Income Taxes - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation </Role>
<ShortName> Income Taxes - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 149 - Disclosure - Summary of Unrecognized Tax Benefits (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfUnrecognizedTaxBenefits </Role>
<ShortName> Summary of Unrecognized Tax Benefits (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 150 - Disclosure - Commitments And Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation </Role>
<ShortName> Commitments And Contingencies - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 151 - Disclosure - Future Minimum Rental Commitments Under Operating Lease Agreements (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureFutureMinimumRentalCommitmentsUnderOperatingLeaseAgreements </Role>
<ShortName> Future Minimum Rental Commitments Under Operating Lease Agreements (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 152 - Disclosure - Stockholders' Equity - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation </Role>
<ShortName> Stockholders' Equity - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 153 - Disclosure - Summary of Option Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfOptionActivity </Role>
<ShortName> Summary of Option Activity (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 154 - Disclosure - Options Outstanding and Exercisable (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureOptionsOutstandingAndExercisable </Role>
<ShortName> Options Outstanding and Exercisable (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 155 - Disclosure - Cash Proceeds Along With Fair Value Disclosures Related to grants Exercises And Vesting Options (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions </Role>
<ShortName> Cash Proceeds Along With Fair Value Disclosures Related to grants Exercises And Vesting Options (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 156 - Disclosure - Segment Information - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation </Role>
<ShortName> Segment Information - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 157 - Disclosure - Summary of Net Revenue by Geographic Location (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocation </Role>
<ShortName> Summary of Net Revenue by Geographic Location (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 158 - Disclosure - Concentrations - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation </Role>
<ShortName> Concentrations - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 159 - Disclosure - Non Recurring Event - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureNonRecurringEventAdditionalInformation </Role>
<ShortName> Non Recurring Event - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 160 - Disclosure - Subsequent Events - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation </Role>
<ShortName> Subsequent Events - Additional Information (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 161 - Disclosure - Consolidated Valuation and Qualifying Accounts and Reserves (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biolase.com/taxonomy/role/DisclosureConsolidatedValuationAndQualifyingAccountsAndReserves </Role>
<ShortName> Consolidated Valuation and Qualifying Accounts and Reserves (Detail) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Info"> Element biol_ProceedsFromSaleOfCommonStockNetOfIssuanceCosts had a mix of decimals attribute values: -5 -3. </Log>
<Log type="Info"> Element us-gaap_AssetImpairmentCharges had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_CommonStockSharesIssued had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_LineOfCreditFacilityAmountOutstanding had a mix of decimals attribute values: -6 -5. </Log>
<Log type="Info"> Element us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_PreferredStockSharesAuthorized had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_RepaymentsOfLinesOfCredit had a mix of decimals attribute values: -5 -3. </Log>
<Log type="Info"> Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice had a mix of decimals attribute values: 1 2. </Log>
<Log type="Info"> Element us-gaap_SharesIssued had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> 'Monetary' elements on report '130 - Disclosure - Basis of Presentation - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '144 - Disclosure - Lines Of Credit And Other Borrowings - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '148 - Disclosure - Income Taxes - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '152 - Disclosure - Stockholders' Equity - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '159 - Disclosure - Non Recurring Event - Additional Information (Detail)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> Process Flow-Through: 103 - Statement - Consolidated Balance sheets </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2010' </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2009' </Log>
<Log type="Info"> Process Flow-Through: 104 - Statement - Consolidated Balance sheets (Parenthetical) </Log>
<Log type="Info"> Process Flow-Through: 105 - Statement - Consolidated Statements of Operations and Comprehensive Loss </Log>
<Log type="Info"> Process Flow-Through: 107 - Statement - Consolidated Statements of Cash Flows </Log>
</Logs>
<InputFiles>
<File> biol-20121231.xml </File>
<File> biol-20121231.xsd </File>
<File> biol-20121231_cal.xml </File>
<File> biol-20121231_def.xml </File>
<File> biol-20121231_lab.xml </File>
<File> biol-20121231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

↑Top
Filing Submission 0001193125-13-110112   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 26, 12:30:15.1am ET